Filing Details
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2009-08-19 09:44:17
- Reporting Period:
- 2009-08-18
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1043914 | Ore Pharmaceuticals Inc. | ORXE | () |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1396131 | J Mark Gabrielson | C/O Ore Pharmaceuticals Inc. 610 Professional Drive, Suite 101 Gaithersburg MD 20879 | Yes | Yes | No | No |
Transaction Summary
| Purchased: | 2,000 shares | Avg. Price: $0.60 | Total Value: $1,190.00 |
| Number of Shares After Transactions: | 4,000 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2009-08-18 | 2,000 | $0.60 | 4,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
